Patented Products 
 Oncology Formulations
  Specialized Therapeutic
    
Segments

 Anaesthetics

 Anthelmintic

 Anti-Asthamatic

 Anti-Bacterials

 Anti-Diabetic

 Anti-Fungal

 Anti-Histaminics

 Anti-Osteoporotic

 Anti-Spasmodics

 Anti-Tussives

 Anti-Ulcerants

 NSAIDs

 Skeletal Muscle Relaxants

 Oncology API
 Specialty APIs
 Chiral intermediates
Skeletal Muscle Relaxants
Robinaxol Methocarbamol 350mg + Paracetamol 250mg
Robinaxol d Methocarbamol 500mg + Diclofenac Potassium 50mg + Paracetamol 325mg
Robini gel Oleum Lini 1% w/w + Diclofenac Diethylammonium 1.16% w/w + Methyl Salicylatye I.P. 10.00% w/w + Capsaicin 0.025% w/w
Robiflam-200 Methocarbamol 750mg + Ibuprofen 200mg
Robiflam-400 Methocarbamol 750mg + Ibuprofen 400mg
Robilid tablet Methocarbamol 1gm + Nimesulide 100mg
Robinax inj Methocarbamol 100mg
Robinax tab Methocarbamol 500mg
 

Present

Introduced Patented Products based on NDDS
(Marketed in India and out-Licensed for the Developing Countries)

  

Future

Patents driven by NDDS, Nano and Dendrimers
(To be marketed in India and to be out Licensed to the developed countries)

 
   
© 2001 - 2007 Khandelwal Laboratories Pvt. Ltd. All rights reserved.